| 1 |
Hodgkins KS, Schnaper HW. Tubulointerstitial injury and the progression of chronic kidney disease [J]. Pediatr Nephrol, 2012,27(6):901-909.
|
| 2 |
Kalamas AG, Niemann CU. Patients with chronic kidney disease[J]. Med Clin North Am,2013,97(6):1109-1122.
|
| 3 |
Xie J, Chen N. Primary glomerulonephritis in mainland China: an overview [J]. Contrib Nephrol,2013,181:1-11.
|
| 4 |
Lichtenstein RG, Rabinovich GA. Glycobiology of cell death: when glycans and lectins govern cell fate [J]. Cell Death Differ, 2013,20(8):976-986.
|
| 5 |
Gallo A, Costantini M. Glycobiology of reproductive processes in marine animals: the state of the art [J]. Mar Drugs, 2012, 10(12):2861-2892.
|
| 6 |
Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease [J]. Cell,2006,126(5):855-867.
|
| 7 |
Honke K. Biosynthesis and biological function of sulfoglycolipids[J]. Proc Jpn Acad Ser B Phys Biol Sci,2013,89(4):129-138.
|
| 8 |
Hashii N, Kawasaki N, Itoh S, et al. Alteration of N-glycosylation in the kidney in a mouse model of systemic lupus erythematosus:relative quantification of N-glycans using an isotope-tagging method[J]. Immunology,2009,126(3):336-345.
|
| 9 |
Narita I,Gejyo F. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy [J]. Clin Exp Nephrol,2008,12(5):332-338.
|
| 10 |
Wang Y, Zhang Z, Shen H, et al. TGF-beta1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI [J]. J Recept Signal Transduct Res,2008,28(4):413-428.
|
| 11 |
Hills CE, Squires PE. The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy [J]. Cytokine Growth Factor Rev,2011,22(3):131-139.
|
| 12 |
Ziyadeh FN, Hoffman BB, Han DC, et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice[J]. Proc Natl Acad Sci USA,2000,97(14):8015-8020.
|
| 13 |
Border WA, Noble NA, Yamamoto T, et al. Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease [J]. Nature,1992,360(6402):361-364.
|
| 14 |
Han DC, Hoffman BB, Hong SW, et al. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice [J]. Am J Physiol Renal Physiol, 2000,278(4):628-634.
|
| 15 |
Abdel-Wahab N, Wicks SJ, Mason RM, et al. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240 [J]. Biochem J,2002,362(3):643-649.
|
| 16 |
Sasaki T, Ito Y, Bringas P Jr, et al. TGF beta-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development [J]. Development,2006,133(2):371-381.
|
| 17 |
Saxena V, Lienesch DW, Zhou M, et al. Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage [J]. J Immunol, 2008,180(3):1903-1912.
|
| 18 |
Ikushima H, Miyazono K. Biology of transforming growth factor-β signaling [J]. Curr Pharm Biotechnol,2011,12(12):2099-2107.
|
| 19 |
Beiting DP, Gagliardo LF, Hesse M, et al . Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-beta [J]. J Immunol,2007,178(2):1039-1047.
|
| 20 |
Petersen M, Thorikay M, Deckers M, et al. Oral administration of GW788388, an inhibitor of TGF-b type Ⅰand Ⅱreceptor kinases,decreases renal fibrosis [J]. Kidney Int,2008,73(6):705-715.
|
| 21 |
Kushibiki T, Nagata-Nakajima N, Sugai M, et al. Delivery of plasmid DNA expressing small interference RNA for TGF-beta typeⅡreceptor by cationized gelatin to prevent interstitial renal fibrosis[J]. J Control Release,2005,105(3):318-331.
|
| 22 |
Solá RJ, Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals [J]. J Pharm Sci, 2009, 98 (4):1223-1245.
|
| 23 |
Wang X,Inoue S, Gu J,et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice [J]. Proc Natl Acad Sci USA,2005,102(44):15791-15796.
|
| 24 |
Wang X, Gu J, Ihara H, et al. Core Fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling[J]. J Biol Chem,2006,281(5):2572-2577.
|
| 25 |
Lin H, Wang D, Wu T, et al. Blocking core fucosylation of TGFβ1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells [J]. Am J Physiol Renal Physiol,2011,300(4): F1017-1025.
|
| 26 |
Shen N, Lin H, Wu T, et al. Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis[J]. Kidney Int,2013,84(1):64-77.
|
| 27 |
Venka tachalam MA, Weinberg JM. New wrinkles in old receptors:core fucosylation is yet another target to inhibit TGF-β signaling[J]. Kidney Int,2013,84(1):11-14.
|
| 28 |
Motoyoshi Y,Matsusaka T,Saito A, et al. Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria[J]. Kidney Int,2008,74(10):1262-1269.
|
| 29 |
Wang Y, Chen J, Chen L, et al. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein[J]. J Am Soc Nephrol,1997,8(10):1537-1545.
|
| 30 |
Zoja C, Donadelli R, Colleoni S, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NFkappa B activation [J]. Kidney Int,1998,53(6):1608-1615.
|